Pharmadrug Inc C.PHRX

Alternate Symbol(s): LMLLF

Medical Care Cannabis

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.

CSE:PHRX - Post by User

Pharmadrug Inc > New debenture raise..to replace current debenture..!

<< Previous

Bullboard Posts

Next >>

Comment by Tommyjohnon Oct 31, 2024 9:30pm

38 Views

Post# 36291707

RE:New debenture raise..to replace current debenture..!

Yes, does seem like good news, but are they not still short on cash.
Still can't figure out the spike a few months back, just to fall flat.
Is there no short terms catalysts in the works? I thought with that spike we would have seen something substantial by now.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement